Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT02740309

Integrated Behavioral Health Innovations in Childhood Chronic Illness Care Delivery Systems

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
NYU Langone Health · Academic / Other
Sex
All
Age
12 Years – 21 Years
Healthy volunteers
Not accepted

Summary

Study design: At baseline, all adolescents and young adults with IBD ages 12-21 years will be screened for anxiety and depression symptoms using the PHQ-9 and the Screen for Child Anxiety Related Disorders (SCARED) during a routine medical visit in the pediatric gastroenterology clinic. Individuals who screen positive for depression or anxiety will be assessed to confirm diagnoses using the anxiety and M.I.N.I. 6.0. Participants will also complete a psychosocial risk assessment as well as medical and socio-demographic inventories. The investigators will include youth that meet full criteria for major depressive disorder and any anxiety disorder, dysthymic disorder, and any adjustment disorder. The investigators will also include patients with subclinical symptoms that have significant psychosocial stressors in addition to their medical illness. Patients will be excluded if they have active suicidal ideation with plan requiring ER referral, bipolar disorder, psychosis, substance dependence, eating disorders, or significant intellectual disability/developmental delay. Participants meeting inclusion criteria will be randomly assigned to four sessions of IBBT administered on-site by a Fink social worker or treatment as usual (TAU), which is a facilitated community referral for mental health treatment.

Conditions

Interventions

TypeNameDescription
BEHAVIORALIntegrated Brief Behavior Therapy (IBBT) InterventionThe 4 sessions will empower and support families and youth to continue treatment autonomously with home practice
BEHAVIORALTreatment as usualFacilitated community referral for mental health treatment

Timeline

Start date
2016-04-01
Primary completion
2018-03-01
Completion
2018-03-01
First posted
2016-04-15
Last updated
2018-12-05

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02740309. Inclusion in this directory is not an endorsement.